Results 21 to 30 of about 78,155 (256)
Nodular regenerative hyperplasia and liver transplantation: a systematic review
Nodular regenerative hyperplasia (NRH) is a primary disease of the liver that may cause noncirrhotic portal hypertension. Common causes include autoimmune, hematologic, immune deficiency, and myeloproliferative disorders. Given the limited data regarding
Ben E. Biesterveld +5 more
doaj +1 more source
Beyond the scope and the glue: update on evaluation and management of gastric varices
Gastric varices are encountered less frequently than esophageal varices. Nonetheless, gastric variceal bleeding is more severe and associated with worse outcomes.
C. Philips +5 more
semanticscholar +1 more source
Background and Aim Gastric antral vascular ectasia (GAVE) is observed in patients with liver cirrhosis and portal hypertension. The exact pathophysiologic mechanism that underlies this condition is unknown.
Magdy Fouad +5 more
doaj +1 more source
Abstract Hepatopulmonary syndrome (HPS) is associated with increased waitlist mortality in liver transplantation (LT) candidates. Children with HPS are granted Model for End‐Stage Liver Disease (MELD)/Pediatric End‐Stage Liver Disease (PELD) exception points for waitlist prioritization in the United States based on criterion developed for adults.
Muhammad H. Raza +8 more
wiley +1 more source
Predictors of variceal rebleeding in liver cirrhosis
Aim: Cirrhotic patients with acute variceal bleeding are characterized by a high mortality and rebleeding rate. The aim of this study was to explore predictors of rebleeding in cirrhotic patients.Methods: Cirrhotic patients who were admitted to the ...
Tuncer Temel +2 more
doaj +1 more source
Schistosomiasis affects about 240 million people worldwide and Schistosoma mansoni alone affects over 54 million people leaving 400 million at-risk especially in Sub Saharan Africa (SSA). About 20 million people are currently suffering from complications
D. Gunda +4 more
semanticscholar +1 more source
Evaluation of non-invasive marker of esophageal varices in cirrhosis of liver
Introduction: Esophageal varices develop as a consequence of portal hypertension (PHT) in patients with chronic liver disease. Hence, screening of all cirrhotic patients with upper gastrointestinal endoscopy to detect the presence of significant ...
Pardeep Kumar +8 more
semanticscholar +1 more source
OBJECTIVE: To evaluate Glasgow Blatchford (GB) scores ability for risk stratification in patients presenting with upper gastrointestinal bleeding (UGIB).
Fatima Khalil +4 more
doaj +1 more source
β-blockers in advanced cirrhosis: More friend than enemy [PDF]
Nonselective beta-adrenergic blocker (NSBB) therapy for the prevention of initial and recurrent gastrointestinal bleeding in cirrhotic patients with gastroesophageal varices has been used for the past four decades.
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
doaj +1 more source
Update on the management of gastrointestinal varices
Cirrhosis of liver is a major problem in the western world. Portal hypertension is a complication of cirrhosis and can lead to a myriad of pathology of which include the development of porto-systemic collaterals.
U. Boregowda +9 more
semanticscholar +1 more source

